(Q36046728)

English

Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Heckford SE

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Eccles SA

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Powles TJ

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Alexander P

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 July 1982

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

46

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

51-57

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Prostaglandin-like material extracted from squamous carcinomas of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Prostaglandins and cancer: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Subversion of immune system by tumor cells and role of prostaglandins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Mechanism of inhibition of tumour growth by aspirin and indomethacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Breast cancer, prostaglandins, and bone metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

2 October 2017

Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

11 July 2018

Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

11 July 2018

Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

11 July 2018

Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

11 July 2018

Tumor-mediated immunosuppression: Prevention by inhibitors of prostaglandin synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

11 July 2018

Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011070

11 July 2018

Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/7104197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7104197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in balb/c mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7104197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7104197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7104197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/7104197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7104197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1982.164

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36046728&oldid=2198124885"